z-logo
Premium
Effects of dexamethasone* on bovine circulating T lymphocyte populations
Author(s) -
Burton Jeanne L.,
Kehrli Marcus E.
Publication year - 1996
Publication title -
journal of leukocyte biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.819
H-Index - 191
eISSN - 1938-3673
pISSN - 0741-5400
DOI - 10.1002/jlb.59.1.90
Subject(s) - dexamethasone , peripheral blood mononuclear cell , cd8 , cd3 , medicine , endocrinology , biology , t lymphocyte , microbiology and biotechnology , antigen , immunology , in vitro , biochemistry
In cattle, γδ T cells represent a higher proportion of circulating T cells than in humans. Bovine γδ T cells can be recognized by expression of γδ T cell receptor (γδ TCR) determinants or by a 215/230‐kDa surface antigen (WC1). WC1 is expressed on 90% or more of circulating bovine γδ T cells. The effects of dexamethasone on this and other subsets (CD3, CD2, CD4, CD8) of peripheral blood T lymphocytes were determined by flow cytometric analysis. Twelve 15‐month old bulls were injected with dexamethasone (0.04 mg/kg/day) for 3 consecutive days and four bulls were untreated controls. Blood samples were collected daily for 3 days before dexamethasone injections and for an additional 7 days starting on the third injection day. Data were recorded as percent positive cells and as mean fluorescent intensity (MFI) of positive cells. Initially, CD3+ cells represented 65–73% of all peripheral blood mononuclear cells (PBMC). Dexamethasone reduced CD3+ cells to 30%, and these recovered to 50% positive cells by 9 days after the last dexamethasone injection. Loss of CD3+ cells was not due to reductions in αβ T cells because dexamethasone did not influence the percent CD2+, CD4+, or CD8+ cells. However, percent WC1+ cells rapidly declined from a baseline of 26.4% of PBMC to < 6% by the final injection. During injections, the MFI of WC1 increased. The MFI of WC1 returned to control values 7 days after the last injection of dexamethasone, but the percent γδ T cells recovered to only 14% WC1 + PBMC by the final day of the study. During its maximum effects on WC1, dexamethasone also caused a profound decrease of L‐selectin MFI on remaining PBMC (mostly αβ T cells and monocyte/macrophages). In a second trial, two‐color analyses determined that dexamethasone did not increase apoptosis in WC1 + cells and did not reduce L‐selectin MFI on either CD2+ or WC1 + cells. The cumulative results suggested that dexamethasone promoted γδ T cell migration out of peripheral blood via an L‐selectin‐independent mechanism and that dexamethasone did not alter αβ T cell migration kinetics.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom